Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma

被引：17

作者：

Oki, Yasuhiro ^{[1
]}

Copeland, Amanda ^{[1
]}

Romaguera, Jorge ^{[1
]}

Fayad, Luis ^{[1
]}

Fanale, Michelle ^{[1
]}

Faria, Silvana de Castro ^{[2
]}

Medeiros, L. Jeffrey ^{[3
]}

Ivy, Percy ^{[4
]}

Younes, Anas ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, Rockville, MD USA

来源：

LEUKEMIA & LYMPHOMA | 2012年 / 53卷 / 05期

关键词：

PHASE-I TRIAL; CELL-CYCLE ARREST; ADVANCED CANCER; ALK EXPRESSION; KINASE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; COMPLEX; AKT;

D O I：

10.3109/10428194.2011.631236

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：990 / 992

页数：3

共 50 条

[31] TRYPANOSOMA-CRUZI HEAT-SHOCK PROTEIN-90 CAN FUNCTIONALLY COMPLEMENT YEAST
PALMER, G
LOUVION, JF
TIBBETTS, RS
ENGMAN, DM
PICARD, D
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 70 (1-2) : 199 - 202
[32] HEAT-SHOCK PROTEIN-90 AS A CRITICAL FACTOR IN MAINTAINING GLUCOCORTICOSTEROID RECEPTOR IN A NONFUNCTIONAL STATE
CADEPOND, F
SCHWEIZERGROYER, G
SEGARDMAUREL, I
JIBARD, N
HOLLENBERG, SM
GIGUERE, V
EVANS, RM
BAULIEU, EE
JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (09) : 5834 - 5841
[33] Extracellular heat shock protein-90α:: linking hypoxia to skin cell motility and wound healing
Li, Wei
Li, Yong
Guan, Shengxi
Fan, Jianhua
Cheng, Chieh-Fang
Bright, Alexandra M.
Chinn, Cindi
Chen, Mei
Woodley, David T.
EMBO JOURNAL, 2007, 26 (05): : 1221 - 1233
[34] Targeting heat shock protein 90 with Ganetespib for the treatment of lymphoma
Tu, Zhigang
Liu, Hanging
Zhao, Jingjing
Zhang, Peishan
Liang, Zhiquan
Ruan, Lingling
Lu, Yongjin
Shang, Dongsheng
Sun, Ying
Xu, Lili
Chen, Keping
Danzeng, Quji
CANCER RESEARCH, 2015, 75
[35] Targeting heat shock protein 90 with ganetespib for the treatment of lymphoma
Liu, Hanqing
Liang, Zhiquan
Zhang, Peishan
Zhao, Jingjing
Ruan, Lingling
Lu, Yongjin
Shang, Dongsheng
Sun, Ying
Tu, Zhigang
MOLECULAR CANCER RESEARCH, 2016, 14
[36] A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
Lipika Goyal
Surendra Pal Chaudhary
Eunice L. Kwak
Thomas A. Abrams
Amanda N. Carpenter
Brian M. Wolpin
Raymond C. Wadlow
Jill N. Allen
Rebecca Heist
Nadine Jackson McCleary
Jennifer A. Chan
Wolfram Goessling
Deborah Schrag
Kimmie Ng
Peter C. Enzinger
David P. Ryan
Jeffrey W. Clark
Investigational New Drugs, 2020, 38 : 1533 - 1539
[37] A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
Goyal, Lipika
Chaudhary, Surendra Pal
Kwak, Eunice L.
Abrams, Thomas A.
Carpenter, Amanda N.
Wolpin, Brian M.
Wadlow, Raymond C.
Allen, Jill N.
Heist, Rebecca
McCleary, Nadine Jackson
Chan, Jennifer A.
Goessling, Wolfram
Schrag, Deborah
Ng, Kimmie
Enzinger, Peter C.
Ryan, David P.
Clark, Jeffrey W.
INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1533 - 1539
[38] Pathogenesis Of Pulmonary Fibrosis: The Role Of Extracellular Heat Shock Protein-90 (hsp90) In Myofibroblast Differentiation And Persistence
Bellaye, P. -S.
Wheildon, N.
Shimbori, C.
Kolb, M. R. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[39] Pathogenesis Of Pulmonary Fibrosis - The Role Of Extracellular Heat Shock Protein-90 (hsp90) In Myofibroblast Differentiation And Persistence
Bellaye, P. -S.
Wheildon, N.
Shimbori, C.
Kolb, M. R. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[40] Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma
Wu, Xinqi
Marmarelis, Melina E.
Hodi, F. Stephen
PLOS ONE, 2013, 8 (02):

← 1 2 3 4 5 →